SUZETTE FLORES: Open Payments
NPI 1487832978 · DOVER, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 4 payments from 3 companies in 2025. Trend: 2023 $424 · 2024 $1,012 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $246 |
| Gilead Sciences, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $59 |
Products named: Epclusa, AIRSUPRA, FASENRA, Auvelity.
Industry payments across DE — which companies pay providers there.
